Compounds > resiquimod
Page last updated: 2024-09-04

resiquimod and HPV Infection

resiquimod has been researched along with HPV Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Da Silva, DM; Fahey, LM; Kast, WM; Raff, AB1
Fraillery, D; Nardelli-Haefliger, D; Zosso, N1
Jones, T1
Hengge, UR; Meykadeh, N1

Reviews

1 review(s) available for resiquimod and HPV Infection

ArticleYear
Resiquimod 3M.
    Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:2

    Topics: Administration, Topical; Antiviral Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contraindications; Eczema; Herpes Simplex; Humans; Imidazoles; Papillomavirus Infections; Structure-Activity Relationship

2003

Other Studies

3 other study(ies) available for resiquimod and HPV Infection

ArticleYear
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
    Journal of immunology (Baltimore, Md. : 1950), 2009, Mar-01, Volume: 182, Issue:5

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Cells, Cultured; Epitopes, T-Lymphocyte; Female; Human papillomavirus 16; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunosuppressive Agents; Langerhans Cells; Papillomavirus Infections; Quinolines; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptor 8; Uterine Cervical Neoplasms

2009
Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles.
    Vaccine, 2009, Apr-14, Volume: 27, Issue:17

    Topics: Adjuvants, Immunologic; Administration, Intravaginal; Administration, Rectal; Animals; Antibodies, Viral; Antibody Formation; Capsid Proteins; Cholera Toxin; Female; Human papillomavirus 16; Humans; Imidazoles; Lipid A; Mice; Mouth; Nonoxynol; Oncogene Proteins, Viral; Papillomavirus Infections; Papillomavirus Vaccines; Rectum; Vaccines, Synthetic; Vagina

2009
[Topical immunomodulators in dermatology].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts

2003